Breaking News Instant updates and real-time market news.

AMCR

Amcor

$10.07

-0.11 (-1.08%)

, APD

Air Products

$229.71

-1.21 (-0.52%)

04:55
12/04/19
12/04
04:55
12/04/19
04:55

Citigroup to hold a conference

2019 Basic Materials Conference will be held in New York on December 2-4.

AMCR

Amcor

$10.07

-0.11 (-1.08%)

APD

Air Products

$229.71

-1.21 (-0.52%)

ARD

Ardagh Group

$18.51

0.105 (0.57%)

BERY

Berry Global

$46.58

-0.07 (-0.15%)

BLL

Ball Corp.

$66.44

0.65 (0.99%)

CCK

Crown Holdings

$75.81

0.01 (0.01%)

CLXT

Calyxt

$4.69

1.05 (28.85%)

CTVA

Corteva

$24.64

-0.54 (-2.14%)

ECL

Ecolab

$185.34

0.22 (0.12%)

EMN

Eastman Chemical

$75.48

-2.91 (-3.71%)

FMC

FMC Corporation

$97.23

-0.53 (-0.54%)

GPK

Graphic Packaging

$16.35

0.03 (0.18%)

HUN

Huntsman

$21.90

-0.7 (-3.10%)

IP

International Paper

$46.09

-0.15 (-0.32%)

LYB

LyondellBasell

$91.75

-0.86 (-0.93%)

MOS

Mosaic

$18.44

-0.56 (-2.95%)

NTR

Nutrien

$46.24

-0.195 (-0.42%)

RYN

Rayonier

$30.68

0.15 (0.49%)

SEE

Sealed Air

$37.33

-0.02 (-0.05%)

SQM

SQM

$23.71

-0.015 (-0.06%)

VNTR

Venator Materials

$3.58

-0.305 (-7.86%)

WRK

WestRock

$39.50

-0.89 (-2.20%)

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

  • 30

    Jan

  • 19

    Feb

AMCR Amcor
$10.07

-0.11 (-1.08%)

10/22/19
10/22/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amcor (AMCR) initiated with an Underperform at Jefferies. 2. Levi Strauss (LEVI) initiated with an Outperform at Macquarie while Kontoor Brands (KTB) was initiated with a Neutral. 3. New Senior Investment (SNR) initiated with an Equalweight at Capital One. 4. Blueprint Medicines (BPMC) resumed with an Outperform at JMP Securities. 5. SPX Corporation (SPXC) initiated with a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/19
JEFF
10/22/19
INITIATION
JEFF
Underperform
Amcor initiated with an Underperform at Jefferies
Jefferies analyst Richard Johnson started Amcor with an Underperform rating and A$12 price target. The analyst is uncertain if the Bemis-related dilution is fulled reflected in the shares despite the recent weakness.
06/20/19
06/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apple (AAPL) initiated with a Hold at Deutsche Bank. 2. Corteva (CTVA) initiated with a Sector Perform at RBC Capital. 3. Amcor (AMCR) initiated with a Buy at Citi. 4. Healthcare Realty Trust (HR) initiated with a Neutral at Citi. 5. Uber (UBER) initiated with a Neutral at Northcoast. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/11/19
FBCO
11/11/19
UPGRADE
FBCO
Outperform
Amcor upgraded to Outperform from Neutral at Credit Suisse (Friday)
Credit Suisse analyst Larry Gandler upgraded Amcor on Friday to Outperform from Neutral with a price target of A$15.50.
APD Air Products
$229.71

-1.21 (-0.52%)

11/18/19
ATLE
11/18/19
INITIATION
Target $250
ATLE
Neutral
Air Products initiated with a Neutral at Atlantic Equities
Atlantic Equities analyst Colin Isaac initiated coverage of Air Products with a Neutral rating and $250 price target.
10/15/19
WELS
10/15/19
INITIATION
Target $240
WELS
Market Perform
Air Products initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Michael Sison initiated coverage of Air Products & Chemicals with a Market Perform rating and $240 price target. The analyst, who believes Air Products is one of the few chemical companies that can consistently generate double-digit earnings growth, says a good amount of the positives are discounted in the stock's current multiple.
11/18/19
11/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BRP Group (BRP) was initiated with an Outperform at Raymond James, Wells Fargo, and Keefe Bruyette, a Buy at BofA/Merrill, a Hold at Jefferies, and a Neutral at JPMorgan. 2. j2 Global (JCOM) initiated with an Overweight at Piper Jaffray. 3. Silvergate Capital (SI) initiated with a Buy at Compass Point. 4. Air Products (APD) initiated with a Neutral at Atlantic Equities. 5. Champions Oncology (CSBR) initiated with a Speculative Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/19
DBAB
11/08/19
NO CHANGE
Target $260
DBAB
Buy
Air Products price target raised to $260 from $250 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised his price target for Air Products (APD) to $260 from $250 saying the company's guidance of 14%-17% earnings growth in 2020 exceeds expectations. The analyst views Air Products' valuation discount to Linde plc (LIN) as unwarranted and he reiterates a Buy rating on the shares.
ARD Ardagh Group
$18.51

0.105 (0.57%)

06/19/19
DBAB
06/19/19
NO CHANGE
DBAB
Buy
Constellium a winner of upcoming can sheet shortage, says Deutsche Bank
The stable demand of aluminum beverage can sheet along with little-to-no investment by production companies has tightened markets, Deutsche Bank analyst Jeremy Kliewer tells investors in a research note. The analyst believes that as legacy can sheet contracts roll-off, new contracts are likely to reflect the tightened supply dynamics through higher pricing. With roughly 50% of Constellium's (CSTM) production/shipment volumes exposed to aluminum can sheet, Kliewer sees the company as the largest beneficiary of upcoming can sheet prices increasing. He raised his 2020-2021 EBITDA estimates by 5% to reflect the company's packaging sheet margins widening and recommends buying the shares. The analyst reiterates a Buy ratings on Constellium and Alcoa (AA), as well as packaging companies Ball Corp. (BLL), Crown Holdings (CCK) and Ardagh Group (ARD).
07/17/19
JPMS
07/17/19
DOWNGRADE
Target $17
JPMS
Underweight
Ardagh Group downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Tyler Langton downgraded Ardagh Group to Underweight from Neutral while raising his price target for the shares to $17 from $15. The analyst says the 7% downside to his target represents the lowest potential return in his Packaging coverage universe. While the company should benefit from the improving volume growth profile of beverage cans, risks from its North American Glass business remain, Langton tells investors in a research note.
BERY Berry Global
$46.58

-0.07 (-0.15%)

09/25/19
09/25/19
UPGRADE

Fly Intel: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Berry Global (BERY) upgraded to Buy on valuation at BofA/Merrill with analyst George Staphos saying he thinks the shares now reflect "a pessimistic, mid-single digit perpetuity decline rate" and concerns on plastics that have been a headwind for sector multiples. 2. Toll Brothers (TOL), Lennar (LEN), and KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James. 3. BancorpSouth (BXS) upgraded to Buy from Hold at SunTrust with analyst Jennifer Demba saying she is positive on the company's "steady" small bank acquisition strategy and its "less asset sensitive" balance sheet, adding that its large mortgage and insurance business help to offset the interest rate related challenges in spread income. 4. Siemens (SIEGY) upgraded to Buy from Hold at HSBC with analyst Michael Hagmann saying with its "Vision 2020+," he believes that before the end of the next decade, Siemens will largely consist of the constituents of Digital Industries, Smart Infrastructure and IIoT related activities such as Mindsphere & Digital Services as well as Siemens Integration Services and separately listed Siemens Healthineers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/25/19
SBSH
11/25/19
NO CHANGE
SBSH
Buy
Citi moves Berry Global to top pick in Paper & Packaging
Citi analyst Anthony Pettinari moved Berry Global to his top pick in Paper & Packaging. He views the company's deleveraging and continued reiteration of its 2020 guidance as key catalysts and his $64 price target implies 42% upside. The analyst keeps a Buy rating on the name.
11/22/19
SBSH
11/22/19
NO CHANGE
Target $64
SBSH
Buy
Berry Global results address sources of investor skeptics, says Citi
Citi analyst Anthony Pettinari says Berry Global's fiscal Q4 results do much to address investor skepticism around engineered materials volumes, HH&S earnings recovery, and European macro concerns. Berry posted sequential improvement in all three items, Pettinari tells investors in a research note. Notably, the shares traded in the low $60's early last year versus yesterday's ~$46 close, the analyst points out. He raised his price target for Berry Global to $64 and reiterates a Buy rating on the name.
10/29/19
BOFA
10/29/19
NO CHANGE
BOFA
Buy
Berry Global added to US 1 List at BofA/Merrill
BLL Ball Corp.
$66.44

0.65 (0.99%)

11/01/19
VERT
11/01/19
UPGRADE
VERT
Hold
Ball Corp. upgraded to Hold from Sell at Vertical Research
Vertical Research analyst Chip Dillon upgraded Ball Corp. to Hold from Sell.
12/02/19
NORL
12/02/19
INITIATION
Target $82
NORL
Outperform
Ball Corp. initiated with an Outperform at Northland
Northland analyst Gus Richard initiated coverage of Ball Corp. with an Outperform rating and $82 price target. He sees beverage containers being in the early innings of a shift from plastic to aluminum, thinks the impact of this transition for Ball is underappreciated and believes it will drive a compound annual growth rate of greater than 7% for Ball over the next 10 years, Richard tells investors.
12/02/19
12/02/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. LyondellBasell (LYB) resumed with an Overweight at Morgan Stanley. 2. Silvergate Capital (SI) initiated with an Overweight at Barclays. 3. SolarEdge (SEDG) initiated with a Buy at Needham. 4. Ball Corp. (BLL) initiated with an Outperform at Northland. 5. Cardlytics (CDLX) initiated with a Buy at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/19
FBCO
10/16/19
NO CHANGE
Target $23
FBCO
Outperform
Constellium a potential supplier for Ball's new plant, says Credit Suisse
Credit Suisse analyst Curt Woodworth maintained an Outperform rating and $23 price target on Constellium (CSTM) after Ball Corp (BLL) announced earlier plans to construct a $200M aluminum cup plant in Georgia, saying Constellium is a potential supplier given its Muscle Shoals plant is just 175 miles from Ball's site in Rome, Georgia. The analyst notes that the secular growth trend in packaging and automotive towards aluminum is a major growth driver for Alcoa (AA) and other aluminum producers as well.
CCK Crown Holdings
$75.81

0.01 (0.01%)

10/21/19
RBCM
10/21/19
NO CHANGE
Target $83
RBCM
Outperform
Crown Holdings price target raised to $83 from $79 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on Crown Holdings to $83 and kept his Outperform rating after its Q3 results. The analyst notes that while the company lowered its FY19 guidance for earnings and free cash flows on a poor harvest in Europe and slower activity in Transit Packaging, its 2020 North America volumes were seen rising about 5% thanks to its capacity expansion. Viswanathan is also positive on Crown Holdings longer term due to the "strong" global "bevcan" volume growth, its favorable pricing, and the sufficient incremental capacity amid rising demand.
10/18/19
DBAB
10/18/19
NO CHANGE
Target $75
DBAB
Buy
Crown Holdings price target raised to $75 from $65 at Deutsche Bank
Deutsche Bank analyst Debbie Jones raised her price target for Crown Holdings to $75 from $65 saying the company's beverage can business continues to perform well. This should be rewarded with a higher relative valuation, which in turn will drive the shares higher, Jones tells investors in a research note. The analyst keeps a Buy rating on Crown Holdings.
11/06/19
BMOC
11/06/19
NO CHANGE
Target $85
BMOC
Outperform
Crown Holdings price target raised to $85 from $72 at BMO Capital
BMO Capital analyst Mark Wilde raised his price target on Crown Holdings to $85 and kept his Outperform rating after its announcement to review its portfolio and capital allocation strategies. The analyst notes that the 2018 acquisition of Signode may be unwound, as the assets have introduced "industrial cyclicality" into a defensive consumer packaging portfolio." Wilde still sees the company among the "best-managed" names in packaging with most stable margins, adding that its 2020 should see benefits from higher North America prices.
11/06/19
WELS
11/06/19
NO CHANGE
Target $85
WELS
Outperform
Crown Holdings price target raised to $85 from $75 at Wells Fargo
Wells Fargo analyst Gabe Hajde raised his price target for Crown Holdings to $85 from $75 and maintained an Outperform rating, saying his firm's sum-of-the-parts analysis points to 7%-15% potential upside from divesting the company's Transit Packaging business. He thinks Crown's announcement regarding a comprehensive review of its business portfolio and capital allocation return/activities is mainly in response to shareholder dissent over the company's early 2018 Signode.
CLXT Calyxt
$4.69

1.05 (28.85%)

03/06/19
NATL
03/06/19
INITIATION
Target $35
NATL
Buy
Calyxt initiated with a Buy at National Securities
National Securities analyst Ben Klieve initiated Calyxt with a Buy and $35 price target.
11/08/19
BMOC
11/08/19
NO CHANGE
Target $15
BMOC
Outperform
Calyxt price target lowered to $15 from $21 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Calyxt to $15 after its Q3 earnings miss, with lower than expected revenue offset in part by the lower operating expenses. The analyst is keeping his Outperform rating on the stock however as he still believes that the company will "transition from proof of concept into established product viability and a fully optimized business model", leveraging its scale and extending its penetration with key customers.
12/17/18
12/17/18
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) upgraded to Buy from Hold at Deutsche Bank with analyst Nicole DeBlase saying she believes the tariffs headwinds facing the company are easing. 2. Calyxt (CLXT) upgraded to Buy from Neutral at Goldman Sachs analyst Adam Samuelson saying the shares are down 42% since his September 7 initiation "despite several positive developments as the company approaches commercialization." 3. Scotts Miracle-Gro (SMG) upgraded to Outperform from Market Perform at Raymond James. 4. Lululemon (LULU) upgraded to Buy from Hold at Stifel with analyst Jim Duffy saying while Lululemon's comps will "inevitably slow against difficult compares," its double-digit revenue growth can continue. 5. Barnes & Noble (BKS) upgraded to Buy from Hold at Craig-Hallum analyst Alex Fuhrman saying initial Q4 checks have indicated improved results, continued cost controls and better holiday sales results, which, combined with the ongoing sales process, should provide "intriguing" upside potential. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/19
JEFF
07/12/19
INITIATION
Target $19
JEFF
Buy
Calyxt assumed with a Buy at Jefferies
Jefferies analyst Laurence Alexander assumed coverage of Calyxt with a Buy rating while lowering his price target for the shares to $19 from $27. With the agriculture cycle turning, driving a better environment for farmer technology adoption, and regulatory trends continuing to favor lower-impact solutions for secular health challenges, Calyxt appears well positioned to create new specialty niches in ag commodities, Alexander tells investors in a research note.
CTVA Corteva
$24.64

-0.54 (-2.14%)

11/12/19
11/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arlo Technologies (ARLO) resumed with a Buy at Deutsche Bank. 2. Clarivate Analytics (CCC) initiated with a Hold at Stifel. 3. Stoke Therapeutics (STOK) initiated with a Buy at BTIG. 4. BioMarin (BMRN), Biogen (BIIB), and Amgen (AMGN) were initiated with a Buy at SunTrust. 5. Corteva (CTVA) initiated with a Buy at Redburn. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/19
SPIN
11/05/19
DOWNGRADE
Target $25
SPIN
Hold
Corteva downgraded to Hold from Buy at Spin-Off Research
Spin-Off Research downgraded Corteva to Hold from Buy with a $25 price target.
11/01/19
JPMS
11/01/19
DOWNGRADE
Target $27
JPMS
Neutral
JPMorgan downgrades Corteva to Neutral, cuts target to $27 from $30
JPMorgan analyst Jeffrey Zekauskas downgraded Corteva to Neutral from Overweight with a price target of $27, down from $30. Domestic corn yields are coming in lower in 2019 than in 2018, and may further decrease, but yields have not been sufficiently low to either lift grain prices or seed prices, Zekauskas tells investors in a research note. Further, the analyst says that while Corteva has yet to publish its Q3 cash flow statement, he does not believe that company "has been strongly cash generative year to date."
11/12/19
REDB
11/12/19
INITIATION
REDB
Buy
Corteva initiated with a Buy at Redburn
Redburn initiated coverage of Corteva with a Buy rating.
ECL Ecolab
$185.34

0.22 (0.12%)

05/01/19
ADAM
05/01/19
NO CHANGE
Target $198
ADAM
Buy
Ecolab price target raised to $198 from $186 at Canaccord
Canaccord analyst Chip Moore raised his price target for Ecolab to $198 from $186 following the company's Q1 results, saying he finds Ecolab "very well positioned" to benefit from the convergence of population growth, resource volatility and rapid industrialization across the world. The company's recurring services model drives high visibility, even in a variable macro environment, Moore contends. He maintains a Buy rating.
08/05/19
BMOC
08/05/19
NO CHANGE
Target $208
BMOC
Market Perform
Ecolab price target raised to $208 from $180 at BMO Capital
BMO Capital analyst John McNulty raised his price target on Ecolab to $208 after its "modest" Q2 earnings beat with a "solid" sales growth in the Industrial segment offsetting the weakness in Energy. The analyst believes that the company's fundamentals should lead to continued double-digit earnings growth in 2019 and 2020 as pricing and "falling raws" offset a challenged macro, but also sees the 20- and 19-times expected 2019 and 2020 EBITDA estimates multiple as "too rich", keeping his Market Perform rating.
07/31/19
ADAM
07/31/19
NO CHANGE
Target $222
ADAM
Buy
Ecolab price target raised to $222 from $198 at Canaccord
Canaccord analyst Chip Moore raised his price target on Ecolab to $222 from $198 following Q2 results which indicated strong execution and favorable macro-trends. The analyst said Ecolab is well positioned to benefit from the convergence of population growth, resource volatility, and rapid industrialization across the world. Moore reiterated his Buy rating on Ecolab shares.
07/31/19
FBCO
07/31/19
NO CHANGE
Target $181
FBCO
Neutral
Ecolab price target raised to $181 from $170 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for Ecolab to $181 from $170 following quarterly results. The analyst reiterates a Neutral rating on the shares.
EMN Eastman Chemical
$75.48

-2.91 (-3.71%)

10/16/19
10/16/19
INITIATION
Target $85

Outperform
Wells Fargo bullish on Eastman Chemical, initiates with an Outperform
As previously reported, Wells Fargo analyst Michael Sison initiated coverage of Eastman Chemical with an Outperform rating and $85 price target. The analyst believes the company has made good strides shifting its portfolio of business to more specialty areas which represents about 70%-75% of its earnings power.
10/11/19
RHCO
10/11/19
NO CHANGE
Target $108
RHCO
Hold
SunTrust sees 'lackluster' September quarter results from chemical companies
SunTrust analyst James Sheehan tells investors in a research note that he expects chemical companies to report in-line to below-consensus Q3 results driven by the trade war, slowing GDP in Europe, weak automotive and manufacturing end markets, loosening supply/demand for certain commodity product chains and FX headwinds. Looking ahead, the analyst sees "cautious" commentary for Q4 given the lack of end market acceleration and continued USD strength. The analyst lowered his price target for Chemours (CC) to $16 from $14, for Dow Inc (DOW) to $46 from $52, for Corteva (CTVA) to $28 from $30, for DuPont (DD) to $68 from $75, for Eastman Chemical (EMN) to $75 from $80, for Element Solutions (ESI) to $10 from $11, for Kraton (KRA) to $24 from $33 and for Kronos Worldwide (KRO) to $12 from $13. Sheehan raised his price target for Celanese (CE) to $120 from $108.
10/15/19
WELS
10/15/19
INITIATION
Target $85
WELS
Outperform
Eastman Chemical initiated with an Outperform at Wells Fargo
Wells Fargo analyst Michael Sison initiated coverage of Eastman Chemical with an Outperform rating and $85 price target.
10/29/19
RHCO
10/29/19
NO CHANGE
Target $80
RHCO
Hold
Eastman Chemical price target raised to $80 from $75 at SunTrust
SunTrust analyst James Sheehan raised his price target on Eastman Chemical to $80 to adjust his model to a "normal" free cash flow to enterprise value yield of 9.6%, but also kept his Hold rating after the company's Q3 earnings miss and a cut in its FY19 guidance. The analyst notes that the management continues to focus on controlling costs and accelerating innovation while indicating that it would consider a restructuring, though he also sees "limited upside" on its valuation given the challenging macro environment.
FMC FMC Corporation
$97.23

-0.53 (-0.54%)

10/31/19
SBSH
10/31/19
NO CHANGE
Target $103
SBSH
Buy
Citi names FMC top pick in Ag, boosts target to $103 from $98
Citi analyst P.J. Juvekar raised his price target for FMC Corporation (FMC) to $103 from $98 saying the company reported "an all-round robust quarter," with growth across most geographies and segments. FMC is now the analyst's top pick in Agriculture, followed by Nutrien (NTR) then CF Industries (CF). He keeps a Buy rating on FMC. Ag chemicals is a better market than fertilizers, which tend to be commoditized, Juvekar tells investors in a research note.
10/31/19
BUCK
10/31/19
NO CHANGE
Target $105
BUCK
Buy
FMC Corporation price target raised to $105 from $100 at Buckingham
Buckingham analyst Dmitry Silversteyn raised his price target for FMC Corporation to $105 from $100 and reiterated a Buy rating, saying he sees significant upside following another beat and raise quarter driven by double-digit organic sales growth led by LATAM, India, China and Pakistan.
10/16/19
BARD
10/16/19
UPGRADE
Target $95
BARD
Outperform
Baird upgrades 'safe-haven' FMC Corporation to Outperform
As previously reported, Baird analyst Ben Kallo upgraded FMC Corporation to Outperform from Neutral with a price target of $95, up from $86. He believes FMC's new product introductions, expected share gains in key markets, and operating leverage can drive revenue and adjusted EBITDA growth in 2020 and beyond, Kallo tells investors. He also sees the company's free cash flow generation allowing it to return cash to shareholders and/or invest in growth, potentially via M&A, he said. Given that he believes FMC's growth is not as tied to the global business cycle as specialty chemical peers, Kallo thinks the stock could be a "safe-haven," he added.
10/16/19
10/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Underweight at Atlantic Equities. 2. FMC Corporation (FMC) upgraded to Outperform from Neutral at Baird with analyst Ben Kallo saying he believes FMC's new product introductions, expected share gains in key markets, and operating leverage can drive revenue and adjusted EBITDA growth in 2020 and beyond. 3. Pure Storage (PSTG) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold saying recent VAR/Distributor checks have reflected positive sentiment suggesting Pure can exceed current Street estimates and he has gained a greater appreciation for the market expansion offered by the new FlashArray//C. 4. PDF Solutions (PDFS) upgraded to Buy from Hold at Craig-Hallum with analyst Christian Schwab saying PDF Solutions is transitioning the company to an analytics software model, and believes that looking out 3-5 years, and in line with management's long term model shared at the company's Analyst Day, it can become a "Rule of 40" SaaS like company with 70% gross margins and in aggregate a 20% top line growth rate and 20% operating margin. 5. Builders FirstSource (BLDR) and BMC Stock Holdings (BMCH) upgraded to Overweight from Equal Weight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPK Graphic Packaging
$16.35

0.03 (0.18%)

01/04/19
UBSW
01/04/19
INITIATION
Target $12
UBSW
Neutral
Graphic Packaging initiated with a Neutral at UBS
UBS analyst Edlain Rodriguez initiated Graphic Packaging with a Neutral rating and $11.50 price target.
01/07/19
SBSH
01/07/19
UPGRADE
Target $27
SBSH
Buy
Silgan Holdings upgraded to Buy from Neutral at Citi
Citi analyst Anthony Pettinari upgraded Silgan Holdings (SLGN) to Buy with an unchanged price target of $27. The analyst says the upgrade reflects a more defensive positioning for Paper & Packaging in 2019. Following 2018's underperformance there are some supportive signs on valuation, with the Packagers' disconnect from Consumer Staples "especially noteworthy," Pettinari tells investors in a research note. Crown Holdings (CCK), Berry Global (BERY) and Graphic Packaging (GPK) are his top picks for 2019.
06/17/19
BARD
06/17/19
NO CHANGE
Target $17
BARD
Outperform
Graphic Packaging shares ready to break higher, says Baird
Baird analyst Ghansham Panjabi noted Graphic Packaging shares have frustrated investors for more than two years but he believes the shares are ready to break higher. He believes margin expansion, an increasingly favorable core volume outlook, and an offensive bias toward free cash flow allocation should help the shares out of their previous holding pattern. Panjabi reiterated his Outperform rating and raised his price target to $17 from $15 on Graphic Packaging shares.
12/27/18
12/27/18
NO CHANGE

Stephens to keep GrubHub, RealPage, Vulcan Materials on 2019 Best Ideas list
Stephens said that it plans to publish a complete updated 2019 Best Ideas list on January 2, but in anticipation it shared the names that are being dropped and the three stocks that will remain on the list. The holdovers are GrubHub (GRUB), RealPage (RP) and Vulcan Materials (VMC). The stocks being removed include Boston Scientific (BSX), Brookdale Senior Living (BKD), Conn's (CONN), CoStar Group (CSGP), Curo Group (CURO), FedEx (FDX), First Financial Bancorp (FFBC), Graphic Packaging (GPK), Hub Group (HUBG), Keane Group (FRAC), KeyCorp (KEY), LKQ Corp. (LKQ), Myriad Genetics (MYGN), SVB Financial (SIVB), Triumph Bancorp (TBK), TrueCar (TRUE) and Union Bankshares (UBSH).
HUN Huntsman
$21.90

-0.7 (-3.10%)

10/16/19
EXAN
10/16/19
DOWNGRADE
Target $23
EXAN
Neutral
Huntsman downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Nicola Tang downgraded Huntsman to Neutral from Outperform with a $23 price target.
10/18/19
JEFF
10/18/19
NO CHANGE
Target $28
JEFF
Buy
Huntsman added to Franchise Picks List at Jefferies
Jefferies analyst Laurence Alexander added Huntsman to his firm's Franchise Picks List. The analyst's 12-18 month price target is $28, or 23% potential upside plus nearly a 3% dividend yield. Fuhrer, he sees a path to over $40 per share "in a sustained cyclical rally" and over $60 "at the peak of a synchronized global up-cycle." If leading indicators continue to turn and investors continue to embrace at least a modest cyclical reflation, Huntsman "should be one of the first and fastest out of the gate," Alexander tells investors in a research note. The analyst has a Buy rating on the shares.
10/28/19
RHCO
10/28/19
NO CHANGE
Target $29
RHCO
Buy
Huntsman price target lowered to $29 from $34 at SunTrust
SunTrust analyst James Sheehan lowered his price target on Huntsman to $29 after its Q3 earnings miss and forecasts of Q4 free cash flow being "lower than seasonally expected", as disclosed in its accompanying conference call. The analyst still keeps his Buy rating on the stock, noting that in spite of the "persistent macro headwinds", Huntsman's MDI margins saw stabilization as inventory destocking appears to have "run its course". Sheehan adds that the 6.3-times forward EBITDA multiple on the stock offers some of the "best values" in the sector.
11/18/19
GSCO
11/18/19
UPGRADE
Target $29
GSCO
Conviction Buy
Huntsman upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Robert Koort added Huntsman to his firm's Americas Conviction List while keeping a Buy rating on the shares with an unchanged price target of $29. The stock's current multiple overlooks the portfolio and balance sheet transformation that has occurred over the last five years, Koort tells investors in a research note. Despite a "markedly improved" business mix, which offers more defensive characteristics relative to prior cycles, Huntsman continues to trade in a manner consistent with its historical trading range, says the analyst. Further, he believes Chemicals investor sentiment is "relatively somber," which could present a "compelling buying opportunity" for the space should the current industrial cycle mirror the 2016 period and not decelerate more dramatically to 2009 levels.
IP International Paper
$46.09

-0.15 (-0.32%)

07/15/19
07/15/19
DOWNGRADE
Target $38

Underweight
International Paper downgraded to Underweight at KeyBanc
As previously reported, KeyBanc analyst Adam Josephson downgraded International Paper to Underweight from Sector Weight with a $38 price target. The analyst believes his below-consensus estimates are biased downward rather than upward given worsening fundamentals in containerboard, pulp, and uncoated freesheet.
10/09/19
SPHN
10/09/19
NO CHANGE
Target $50
SPHN
Equal Weight
International Paper dividend raise 'a small but encouraging step,' says Stephens
Stephens analyst Mark Connelly called International Paper's announcement of a 2.5% dividend increase "a small but encouraging step" at a time when its CEO must convince investors that the company will be more shareowner-friendly than it has been in the past and investor confidence in the company's best business is flagging. Investors should see the dividend hike as reassuring and part of an encouraging pattern of capital allocation since Mark Sutton took over, said Connelly, who keeps a $50 price target and Equal Weight rating on International Paper shares.
12/02/19
EXAN
12/02/19
INITIATION
Target $53
EXAN
Outperform
International Paper initiated with an Outperform at Exane BNP Paribas
Exane BNP Paribas initiated coverage of International Paper with an Outperform rating and $53 price target.
07/15/19
KEYB
07/15/19
DOWNGRADE
Target $38
KEYB
Underweight
International Paper downgraded to Underweight from Sector Weight at KeyBanc
KeyBanc analyst Adam Josephson downgraded International Paper to Underweight from Sector Weight with a $38 price target.
LYB LyondellBasell
$91.75

-0.86 (-0.93%)

12/02/19
MSCO
12/02/19
DOWNGRADE
Target $58
MSCO
Equal Weight
Morgan Stanley downgrades Dow to Equal Weight, prefers LyondellBasell in 2020
As previously reported, Morgan Stanley analyst Vincent Andrews downgraded Dow Inc. (DOW) to Equal Weight from Overweight with an unchanged price target of $58. Concurrently, Andrews resumed coverage of LyondellBasell (LYB) with an Overweight rating and $110 price target. Though he notes his price target for LyondellBasell, with 19% upside, "is generally not enough for us to advise putting new money to work in a commodity chemical stock," Andrews believes investors should own a commodity name in 2020 and said the polyethylene chain is where he sees the best commodity chemical risk/reward. Consensus expectations for Dow imbed much more improvement in 2020 than they do for LyondellBasell, added Andrews, who also views Lyondell's ability to keep buying back stock and possibly raise its dividend as another key differentiator between the two stocks in 2020.
11/18/19
JPMS
11/18/19
NO CHANGE
Target $84
JPMS
Underweight
JPMorgan boosts LyondellBasell target but still inclined to be short
JPMorgan analyst Jeffrey Zekauskas raised his price target for Underweight-rated LyondellBasell to $84 from $69. The analyst says his inclination is not to be long the shares but to be on the short side. Polyethylene prices rose in September stemming from production outages in the U.S. and following the attack on the Saudi Arabian oil assets, Zekauskas tells investors in a research note. He thinks that contract polyethylene prices can fall in November and then decrease another few cents into 2020 as non-contract discounts. Global demand for chemicals is actually weaker now than it was in August, says the analyst, who thinks these factors are likely to weigh on the shorter-term price performance of LyondellBasell shares.
12/02/19
MSCO
12/02/19
INITIATION
Target $110
MSCO
Overweight
LyondellBasell resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Vincent Andrews resumed coverage of LyondellBasell with an Overweight rating and $110 price target.
MOS Mosaic
$18.44

-0.56 (-2.95%)

11/13/19
JPMS
11/13/19
DOWNGRADE
Target $18
JPMS
Underweight
Mosaic downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Underweight from Neutral with a price target of $18, down from $20. The analyst says his 2020 EBITDA forecast for Mosaic of $1.56B is about 15% lower than the Street consensus as he assumes lower potash and phosphate returns for Mosaic. He believes the domestic phosphate market did decline in 2019, which has led to low prices in the U.S. because of weak supply/demand balances.
11/06/19
JPMS
11/06/19
DOWNGRADE
Target $20
JPMS
Neutral
JPMorgan downgrades Mosaic, sees better entry points ahead
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Neutral from Overweight with a price target of $20, down from $24. The analyst "substantially" reduced his EBITDA forecast for Mosaic in 2020 due to weak pricing dynamics in both potash and phosphate fertilizers. The company is "worthwhile long-term investment," but more appropriate entry points into the shares can be achieved in the coming months, Zekauskas tells investors in a research note.
11/06/19
JPMS
11/06/19
DOWNGRADE
Target $20
JPMS
Neutral
Mosaic downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Neutral from Overweight with a $20 price target.
10/25/19
CLVD
10/25/19
NO CHANGE
CLVD
CF Industries, Mosaic estimates lowered at Cleveland Research
Cleveland Research analyst Mike Piken lowered his FY19 estimates for both CF Industries (CF) and Mosaic (MOS) to reflect the fact that phosphate market conditions have continued deteriorating and he sees increased odds of an average to worse fall fertilizer application season in the U.S. Piken has Neutral ratings on both stocks.
NTR Nutrien
$46.24

-0.195 (-0.42%)

11/19/19
SUSQ
11/19/19
NO CHANGE
Target $61
SUSQ
Positive
Nutrien price target lowered to $61 from $65 at Susquehanna
Susquehanna analyst Don Carson lowered his price target on Nutrien to $61 from $65 due to reduced wholesale nitrogen and potash shipments and prices following an abbreviated US spring season, expectations for a limited fall application season, and weaker offshore potash demand as China remains out of the market until the first half of 2020. Carson maintained his Positive rating on Nutrien shares.
11/25/19
BOFA
11/25/19
UPGRADE
BOFA
Buy
Nutrien upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded Nutrien to Buy from Neutral.
11/25/19
BOFA
11/25/19
UPGRADE
BOFA
Buy
BofA upgrades CF Industries, Nutrien to Buy with nitrogen seen nearing trough
BofA Merrill Lynch analyst Steve Byrne upgraded CF Industries (CF) and Nutrien (NTR), each to Buy from Neutral, as he expects a price inflection by Spring in all three major nutrients after a year of markedly lower fertilizer prices. Strong demand in North America, Brazil, and India should facilitate quick drawdowns and increased purchasing despite high phosphate and potash inventories, while he also sees limited capacity expansions and lower global exports tightening the market, Byrne tells investors.
RYN Rayonier
$30.68

0.15 (0.49%)

11/01/19
DADA
11/01/19
UPGRADE
DADA
Buy
Rayonier upgraded to Buy from Neutral at DA Davidson
DA Davidson upgraded Rayonier to Buy from Neutral.
04/02/19
GHSC
04/02/19
INITIATION
GHSC
Neutral
Rayonier initiated with a Neutral at Seaport Global
Seaport Global analyst Mark Weintraub started Rayonier (RYN) with a Neutral rating and no price target. The stock's valuation is "perhaps a bit less attractive" relative to the other timber real estate investment trusts, Weintraub tells investors in a research note. The analyst this morning also initiated coverage of PotlatchDeltic (PCH) with a Buy rating and reiterated a Buy rating on Weyerhaeuser (WY). Weintraub admits, however, that Rayonier is more of a "pure-play" in the timberland space than those two companies and that its management has made good decisions of late for its shareholders.
08/08/19
BMOC
08/08/19
NO CHANGE
Target $30
BMOC
Market Perform
Rayonier price target lowered to $30 from $34 at BMO Capital
BMO Capital analyst Mark Wilde lowered his price target on Rayonier to $30 and kept his Market Perform rating after its Q2 results and lowered FY19 EBITDA view to $245M-265M from $270M-290M. The analyst says the company's New Zealand business has been impacted by a "sharp drop in export log prices to China", while its Pacific Northwest volume and prices were "hit by trade uncertainty and a sluggish domestic lumber market."
11/01/19
DADA
11/01/19
UPGRADE
Target $33
DADA
Buy
Rayonier upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Steven Chercover upgraded Rayonier to Buy from Neutral with a $33 price target. The analyst notes that while the company's Q3 results missed expectations, after an 8% decline in its stock price, shares now trade at an "attractive" 21% discount relative to his net asset value estimate. Chercover also expects some of the challenges that pressured Rayonier's performance this year to dissipate in 2020, stating that its exposure to "stable" U.S. timber assets present an opportunity.
SEE Sealed Air
$37.33

-0.02 (-0.05%)

11/07/19
KEYB
11/07/19
UPGRADE
KEYB
Sector Weight
Sealed Air upgraded to Sector Weight on valuation at KeyBanc
KeyBanc analyst Adam Josephson upgraded Sealed Air to Sector Weight from Underweight. In a research note to investors, Josephson says that shares have underperfomed the S&P 500 by 1,400 bps since its downgrade on July 14. While he is upgrading the shares on valuation, Josephson says that "numerous" risks remain, including high leverage, poor recent free cash flow conversion, and ongoing investigations by the SEC and U.S. Attorney.
11/07/19
BARD
11/07/19
NO CHANGE
Target $50
BARD
Outperform
Sealed Air shares appear to be oversold, says Baird
Baird analyst Ghansham Panjabi said Sealed Air shares appear to be oversold following its earnings report making the shares incrementally more attractive at current levels. The analyst said volume weakness in its Product Care segment continues to weigh on investor sentiment but the Street is overlooking its cost savings momentum and related operating leverage. Panjabi reiterated his Outperform rating and $50 price target on Sealed Air shares.
11/07/19
11/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Regeneron (REGN) upgraded to Buy from Neutral at Citi with analyst Mohit Bansal saying the Libtayo data in 2020 and continuous Dupixent growth will make it easy to keep owning Regeneron shares through near-term Eylea competition. 2. Match Group (MTCH) upgraded to Buy from Neutral at UBS with analyst Eric Sheridan saying Match shares experience a post-earnings selloff yesterday after already being notably down since August on the back of the Facebook (FB) Dating launch and legal proceedings. 3. Sealed Air (SEE) upgraded to Sector Weight from Underweight at KeyBanc with analyst Adam Josephson saying shares have underperformed the S&P 500 by 1,400 bps since its downgrade on July 14. 4. Elanco (ELAN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the current valuation on the stock discounts investor concerns regarding the impact on its swine products from African Swine Fever and competitive threats, noting that his rating change reflects an opportunity on the stock following the recent pullback in price. 5. DexCom (DXCM) upgraded to Buy from Neutral at Guggenheim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/19
BARD
11/18/19
NO CHANGE
Target $50
BARD
Outperform
Sealed Air earnings selloff overdone, says Baird
Baird analyst Ghansham Panjabi believes the post earnings selloff in Sealed Air appears to be overdone but he said its volumes are likely to remain mixed in the near-term. He noted its execution on cost savings coupled with improving free cash flow 2020 onward gives him increased conviction as its margin profile is easily best-in-class among its peers. Panjabi reiterated his Outperform rating and $50 price target on Sealed Air shares.
SQM SQM
$23.71

-0.015 (-0.06%)

08/23/19
BMOC
08/23/19
NO CHANGE
Target $24
BMOC
Market Perform
SQM price target lowered to $24 from $31 at BMO Capital
BMO Capital analyst Joel Jackson lowered his price target on SQM to $24 and kept his Market Perform rating to reflect his reduced price expectations for lithium and potassium nitrate. The analyst contends that the company's expected 2019 EBITDA of about $674M would represent its lowest earnings since 2009, and he expects minimal earnings growth next year given the management's focus on selling lithium "no matter the price". Jackson adds that SQM will remain challenged in lithium from higher supply than demand and continued mix issues.
11/22/19
MSCO
11/22/19
NO CHANGE
Target $50
MSCO
Underweight
Albemarle price target lowered to $50 from $60 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered his price target for Albermarle (ALB) shares to $50 from $60 and keeps an Underweight rating on the stock, citing his lower 2020 EBITDA forecast, a lower EBITDA multiple for the lithium segment and the company's increase in leverage due to the MinRes JV purchase. While it has become the consensus view that lithium is oversupplied, expectations for 2021 and beyond on both demand and price remain too optimistic, contends Andrews. He keeps an Equal Weight rating on SQM (SQM) with a $31 price target, down from $34, citing his view that relative valuation and earnings momentum create opportunities when compared to Albemarle.
08/22/19
08/22/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Wells Fargo with analyst Truman Patterson saying although the shares trade at roughly Book Value, he believes the equity lacks a catalyst over the near-to-intermediate term to drive outperformance. 2. SQM (SQM) downgraded to Underweight from Neutral at JPMorgan with analyst Lucas Ferreira citing significant exposure to the deteriorating Chinese market. 3. Fortis (FTS) downgraded to Neutral from Outperformer at CIBC. 4. Splunk (SPLK) downgraded to Neutral from Outperform at Baird with analyst Rob Oliver citing the company's meaningful OCF reduction that stems from the accelerating move to ratable business and reducing up-front invoice durations. 5. Hemispherx (HEB) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing capital concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/26/19
SBSH
08/26/19
NO CHANGE
Target $25
SBSH
Neutral
SQM price target lowered to $25 from $33 at Citi
In a research note partially titled "Still Too Early," Citi analyst Andrew McCarthy lowered his price target for SQM to $25 from $33 and reiterates a Neutral rating on the shares. It remains too early to get more positive on the stock given the recent "weak" lithium market data and downward consensus earnings revisions ahead, McCarthy tells investors. He sees the stock as fairly valued at current levels.
VNTR Venator Materials
$3.58

-0.305 (-7.86%)

08/16/19
BOFA
08/16/19
NO CHANGE
BOFA
BofA/Merrill shakes up ratings in chemicals space with 2 upgrades, 4 downgrades
BofA Merrill Lynch analyst Steve Byrne said it appears that risks of U.S. economic contagion from the broader global macro slowdown are "steadily building." Given this view, he has generally moved to be more cautious on the earnings outlook and ratings for stocks with global industrial exposure, resulting in his upgrade of two chemicals stocks and his downgrades of four others. Byrne downgraded Dow Inc. (DOW) to Underperform from Neutral and Westlake Chemical (WLK) to Underperform from Buy, noting their commodity exposure. He downgraded Axalta Coating (AXTA) to Neutral from Buy and cut PPG (PPG) to Underperform from Neutral as he is getting more cautious about their revenue prospects. He upgraded Venator Materials (VNTR) to Buy from Underperform, citing what he views as an attractive risk-reward as he expects earnings will grow in 2020, driven by product upgrades and productivity initiatives. Byrne also upgraded Nutrien (NTR) to Neutral from Underperform as he believes Ag stocks could prove to be defensive plays.
08/16/19
BOFA
08/16/19
UPGRADE
BOFA
Buy
Venator Materials upgraded to Buy from Underperform at BofA/Merrill
11/18/19
GSCO
11/18/19
UPGRADE
Target $6
GSCO
Buy
Venator Materials upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Robert Koort upgraded Venator Materials to Buy from Neutral with a price target of $6, up from $4. The company as offers some of the greatest leverage to a macro cyclical upturn considering that the stock trades well below what its "normalized valuation," Koort tells investors in a research note. When coupled with improved TiO2 industry behavior as producers pursue a stabilization strategy, the analyst sees ~50% upside in Venator Materials shares.
11/22/19
UBSW
11/22/19
DOWNGRADE
Target $3.75
UBSW
Neutral
Venator Materials downgraded to Neutral from Buy at UBS
UBS analyst Joshua Spector downgraded Venator Materials to Neutral from Buy with an unchanged price target of $3.75.
WRK WestRock
$39.50

-0.89 (-2.20%)

11/18/19
11/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. WestRock (WRK) upgraded to Buy from Neutral at BofA/Merrill with analyst George Staphos saying his takeaway from investor events attended last week suggests that the macro and sector trends for integrated containerboard companies are stable to improving and also believes that the risks in the industry are "not new." 2. Rockwell Automation (ROK) upgraded to Overweight from Equal Weight at Barclays analyst Julian Mitchell saying the stock remains out of favor with the investment community, but the recent earnings report suggests "grounds for optimism." 3. Splunk (SPLK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss saying once Splunk is through its shift to a 100% recurring revenue model and annual invoicing, investors will have better visibility into a company well positioned for key secular trends in data and monitoring. 4. Owens Corning (OC) upgraded to Outperform from Market Perform at Wells with analyst Truman Patterson saying his industry contacts suggest Owens Corning announced an 8% U.S. residential insulation price hike for both loose-fill and batt and roll on Friday, effective January 13. 5. Wolverine World Wide (WWW) upgraded to Buy from Hold at Argus with analyst John Staszak saying he believes that the company will benefit from growth in footwear spending, particularly as the economy improves and consumer confidence increases. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/19
BOFA
11/18/19
UPGRADE
Target $48
BOFA
Buy
WestRock upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst George Staphos upgraded WestRock to Buy from Neutral with a $48 price target. The analyst notes that his takeaway from investor events attended last week suggests that the macro and sector trends for integrated containerboard companies are stable to improving and also believes that the risks in the industry are "not new". Staphos adds that containerboard demand trends in North America appear to be improving, even it is "only a seasonal bump".
11/18/19
BOFA
11/18/19
UPGRADE
BOFA
Buy
WestRock upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded WestRock to Buy from Neutral.
12/02/19
EXAN
12/02/19
INITIATION
Target $48
EXAN
Outperform
WestRock initiated with an Outperform at Exane BNP Paribas
Exane BNP Paribas initiated coverage of WestRock with an Outperform rating and $48 price target.

TODAY'S FREE FLY STORIES

OXY

Occidental Petroleum

$37.34

-0.07 (-0.19%)

18:14
12/09/19
12/09
18:14
12/09/19
18:14
Hot Stocks
Occidental Petroleum director buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

, CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

17:56
12/09/19
12/09
17:56
12/09/19
17:56
Hot Stocks
Mesabi Trust initiates arbitration against Northshore Mining, Cleveland-Cliffs »

The Trustees of Mesabi…

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$24.67

0.12 (0.49%)

17:51
12/09/19
12/09
17:51
12/09/19
17:51
Hot Stocks
First Financial Bancorp chairman Davis sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRE

Green Plains

$14.26

-0.49 (-3.32%)

17:47
12/09/19
12/09
17:47
12/09/19
17:47
Hot Stocks
Green Plains CEO Todd Becker sold over 607K in company shares »

Green Plains CEO Todd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$111.12

-2.02 (-1.79%)

17:43
12/09/19
12/09
17:43
12/09/19
17:43
Hot Stocks
Medtronic director buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

VAC

Marriott Vacations

$123.77

-0.1 (-0.08%)

17:41
12/09/19
12/09
17:41
12/09/19
17:41
Hot Stocks
Marriott Vacations raises quarterly dividend to 54c from 45c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLY

Fastly

$20.82

-0.35 (-1.65%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Fastly director Sunil Dhaliwal sells almost $576K in company shares »

Fastly director Sunil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Stitch Fix says saw healthy growth in both women's, men's categories »

Says shows online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

F

Ford

$9.00

-0.015 (-0.17%)

17:32
12/09/19
12/09
17:32
12/09/19
17:32
Hot Stocks
Ford expects to roughly halve 2018 China EBIT loss »

During a meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 07

    Jan

  • 04

    Feb

VEEV

Veeva

$143.56

-1.115 (-0.77%)

17:28
12/09/19
12/09
17:28
12/09/19
17:28
Hot Stocks
Veeva CMO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BLDR

Builders FirstSource

$25.71

0.45 (1.78%)

17:25
12/09/19
12/09
17:25
12/09/19
17:25
Hot Stocks
Builders FirstSource acquires assets of Raney Components, Construction »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

S

Sprint

$5.40

-0.145 (-2.62%)

, TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

17:16
12/09/19
12/09
17:16
12/09/19
17:16
Periodicals
Judge seeks speedy trial over T-Mobile, Sprint deal, WSJ reports »

U.S. District Judge…

S

Sprint

$5.40

-0.145 (-2.62%)

TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 16

    Dec

WEN

Wendy's

$21.72

0.15 (0.70%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Wendy's sees FY20 FCF of $210M-$220M including impact of settlement »

As a result of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BANX

StoneCastle

$22.99

0.25 (1.10%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneCastle »

StoneCastle trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$130.91

-0.66 (-0.50%)

17:14
12/09/19
12/09
17:14
12/09/19
17:14
Hot Stocks
Assurant director sells 21.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XAIR

Beyond Air

$4.13

0.005 (0.12%)

17:14
12/09/19
12/09
17:14
12/09/19
17:14
Syndicate
Beyond Air announces offering of common stock, concurrent private placement »

Beyond Air announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

, UPWK

Upwork

$11.15

-0.16 (-1.41%)

17:10
12/09/19
12/09
17:10
12/09/19
17:10
Hot Stocks
Upwork CEO Stephane Kasriel to step down, Hayden Brown to succeed »

Upwork (UPWK) announced…

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

UPWK

Upwork

$11.15

-0.16 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

, MSFT

Microsoft

$151.35

-0.42 (-0.28%)

17:10
12/09/19
12/09
17:10
12/09/19
17:10
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks slid to kick off…

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

ARQL

ArQule

$19.71

10.035 (103.77%)

THOR

Synthorx

$67.72

42.74 (171.10%)

SNY

Sanofi

$45.30

-0.755 (-1.64%)

DPLO

Diplomat Pharmacy

$3.91

-1.91 (-32.82%)

UNH

UnitedHealth

$277.56

-2.62 (-0.94%)

MS

Morgan Stanley

$49.60

-0.2 (-0.40%)

VIAC

ViacomCBS

$38.65

-1.05 (-2.64%)

VIACA

ViacomCBS

$41.78

-1.64 (-3.78%)

FTSV

Forty Seven

$30.44

16.04 (111.39%)

FATE

Fate Therapeutics

$19.32

5.68 (41.64%)

TTWO

Take-Two

$120.07

-3.69 (-2.98%)

THO

Thor Industries

$64.28

-3.485 (-5.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

BANX

StoneCastle

$22.99

0.25 (1.10%)

17:09
12/09/19
12/09
17:09
12/09/19
17:09
Hot Stocks
ArrowMark Partners to acquire StoneCastle Asset Management »

StoneCastle Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$21.72

0.15 (0.70%)

17:08
12/09/19
12/09
17:08
12/09/19
17:08
Hot Stocks
Wendy's to realign resources in its information technology organization »

On December 5, the Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

INVH

Invitation Homes

$30.14

0.12 (0.40%)

17:05
12/09/19
12/09
17:05
12/09/19
17:05
Hot Stocks
Invitation Homes sells 708 Nashville homes to Tricon for $210M »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$38.22

-0.14 (-0.36%)

17:04
12/09/19
12/09
17:04
12/09/19
17:04
Hot Stocks
Brown & Brown enters agreement to acquire Special Risk Insurance Managers »

J. Scott Penny, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PYX

Pyxus

$7.40

-0.345 (-4.45%)

, PM

Philip Morris

$83.60

0.34 (0.41%)

17:02
12/09/19
12/09
17:02
12/09/19
17:02
Hot Stocks
Alliance One expands relationship with Philip Morris' Argentine affiliate »

Alliance One…

PYX

Pyxus

$7.40

-0.345 (-4.45%)

PM

Philip Morris

$83.60

0.34 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$89.69

0.2 (0.22%)

17:01
12/09/19
12/09
17:01
12/09/19
17:01
Hot Stocks
Tyson Fresh Meats signs agreement with Republic of Kazakhstan »

Tyson Fresh Meats, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.